Literature DB >> 16971424

The NS1 gene contributes to the virulence of H5N1 avian influenza viruses.

Zejun Li1, Yongping Jiang, Peirong Jiao, Aiqin Wang, Fengju Zhao, Guobin Tian, Xijun Wang, Kangzhen Yu, Zhigao Bu, Hualan Chen.   

Abstract

In the present study, we explored the genetic basis underlying the virulence and host range of two H5N1 influenza viruses in chickens. A/goose/Guangdong/1/96 (GS/GD/1/96) is a highly pathogenic virus for chickens, whereas A/goose/Guangdong/2/96 (GS/GD/2/96) is unable to replicate in chickens. These two H5N1 viruses differ in sequence by only five amino acids mapping to the PA, NP, M1, and NS1 genes. We used reverse genetics to create four single-gene recombinants that contained one of the sequence-differing genes from nonpathogenic GS/GD/2/96 and the remaining seven gene segments from highly pathogenic GS/GD/1/96. We determined that the NS1 gene of GS/GD/2/96 inhibited the replication of GS/GD/1/96 in chickens, while the substitution of the PA, NP, or M gene did not change the highly pathogenic properties of GS/GD/1/96. Conversely, of the recombinant viruses generated in the GS/GD/2/96 background, only the virus containing the NS1 gene of GS/GD/1/96 was able to replicate and cause disease and death in chickens. The single-amino-acid difference in the sequence of these two NS1 genes resides at position 149. We demonstrate that a recombinant virus expressing the GS/GD/1/96 NS1 protein with Ala149 is able to antagonize the induction of interferon protein levels in chicken embryo fibroblasts (CEFs), but a recombinant virus carrying a Val149 substitution is not capable of the same effect. These results indicate that the NS1 gene is critical for the pathogenicity of avian influenza virus in chickens and that the amino acid residue Ala149 correlates with the ability of these viruses to antagonize interferon induction in CEFs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971424      PMCID: PMC1642184          DOI: 10.1128/JVI.00993-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice.

Authors:  Nicola R Donelan; Christopher F Basler; Adolfo García-Sastre
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 2.  Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein.

Authors:  Robert M Krug; Weiming Yuan; Diana L Noah; Anita Ghate Latham
Journal:  Virology       Date:  2003-05-10       Impact factor: 3.616

3.  Naturally occurring NS gene variants in an avian influenza virus isolate.

Authors:  M L Perdue
Journal:  Virus Res       Date:  1992-05       Impact factor: 3.303

4.  Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells.

Authors:  Y Kawaoka; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  The influenza virus NS1 protein forms multimers in vitro and in vivo.

Authors:  M E Nemeroff; X Y Qian; R M Krug
Journal:  Virology       Date:  1995-10-01       Impact factor: 3.616

6.  Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS.

Authors:  Diana L Noah; Karen Y Twu; Robert M Krug
Journal:  Virology       Date:  2003-03-15       Impact factor: 3.616

7.  Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

Authors:  J Talon; M Salvatore; R E O'Neill; Y Nakaya; H Zheng; T Muster; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

8.  Recombinant vesicular stomatitis viruses from DNA.

Authors:  N D Lawson; E A Stillman; M A Whitt; J K Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  Newcastle disease virus V protein is a determinant of host range restriction.

Authors:  Man-Seong Park; Adolfo García-Sastre; Jerome F Cros; Christopher F Basler; Peter Palese
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  The evolution of H5N1 influenza viruses in ducks in southern China.

Authors:  H Chen; G Deng; Z Li; G Tian; Y Li; P Jiao; L Zhang; Z Liu; R G Webster; K Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-02       Impact factor: 11.205

View more
  143 in total

1.  Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.

Authors:  Jinying Ge; Xijun Wang; Lihong Tao; Zhiyuan Wen; Na Feng; Songtao Yang; Xianzhu Xia; Chinglai Yang; Hualan Chen; Zhigao Bu
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009.

Authors:  Yanbing Li; Jianzhong Shi; Gongxun Zhong; Guohua Deng; Guobin Tian; Jinying Ge; Xianying Zeng; Jiasheng Song; Dongming Zhao; Liling Liu; Yongping Jiang; Yuntao Guan; Zhigao Bu; Hualan Chen
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

3.  Phylogenetic analysis of the non-structural (NS) gene of influenza A viruses isolated in Kazakhstan in 2002-2009.

Authors:  Andrey Bogoyavlenskiy; Vladimir Berezin; Alexey Prilipov; Ilya Korotetskiy; Irina Zaitseva; Aydyn Kydyrmanov; Kobey Karamedin; Nailya Ishmukhametova; Saule Asanova; Marat Sayatov; Kainar Zhumatov
Journal:  Virol Sin       Date:  2011-12-10       Impact factor: 4.327

4.  Isolation and molecular characterization of a H5N1 virus isolated from a Jungle crow (Corvus macrohynchos) in India.

Authors:  S Nagarajan; C Tosh; H V Murugkar; G Venkatesh; M Katare; R Jain; P Behera; R Khandia; S Tripathi; D D Kulkarni; S C Dubey
Journal:  Virus Genes       Date:  2010-04-16       Impact factor: 2.332

5.  Avian influenza virus hemagglutinins H2, H4, H8, and H14 support a highly pathogenic phenotype.

Authors:  Jutta Veits; Siegfried Weber; Olga Stech; Angele Breithaupt; Marcus Gräber; Sandra Gohrbandt; Jessica Bogs; Jana Hundt; Jens P Teifke; Thomas C Mettenleiter; Jürgen Stech
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

6.  Variability of NS1 proteins among H9N2 avian influenza viruses isolated in Israel during 2000-2009.

Authors:  A Panshin; N Golender; I Davidson; S Nagar; M Garsia; M W Jackwood; E Mundt; A Alturi; S Perk
Journal:  Virus Genes       Date:  2010-08-19       Impact factor: 2.332

7.  Mutations in PB1, NP, HA, and NA Contribute to Increased Virus Fitness of H5N2 Highly Pathogenic Avian Influenza Virus Clade 2.3.4.4 in Chickens.

Authors:  Sung-Su Youk; Christina M Leyson; Brittany A Seibert; Samadhan Jadhao; Daniel R Perez; David L Suarez; Mary J Pantin-Jackwood
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

Review 8.  The avian and mammalian host range of highly pathogenic avian H5N1 influenza.

Authors:  Bryan S Kaplan; Richard J Webby
Journal:  Virus Res       Date:  2013-09-08       Impact factor: 3.303

9.  The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV.

Authors:  Wenjun Ma; Dominique Brenner; Zhongfang Wang; Bianca Dauber; Christina Ehrhardt; Katrin Högner; Susanne Herold; Stephan Ludwig; Thorsten Wolff; Kangzhen Yu; Jürgen A Richt; Oliver Planz; Stephan Pleschka
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

10.  Acquisition of a polybasic hemagglutinin cleavage site by a low-pathogenic avian influenza virus is not sufficient for immediate transformation into a highly pathogenic strain.

Authors:  Olga Stech; Jutta Veits; Siegfried Weber; Daniela Deckers; Diana Schröer; Thomas W Vahlenkamp; Angele Breithaupt; Jens Teifke; Thomas C Mettenleiter; Jürgen Stech
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.